Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1985 1
1986 1
2016 1
2017 1
2019 4
2020 12
2021 11
2022 14
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients.
Mikulska M, Sepulcri C, Dentone C, Magne F, Balletto E, Baldi F, Labate L, Russo C, Mirabella M, Magnasco L, Di Grazia C, Ghiggi C, Raiola AM, Giacobbe DR, Vena A, Beltramini S, Bruzzone B, Lemoli RM, Angelucci E, Bassetti M. Mikulska M, et al. Among authors: magnasco l. Clin Infect Dis. 2023 Jul 26;77(2):280-286. doi: 10.1093/cid/ciad181. Clin Infect Dis. 2023. PMID: 36976301
Antibiotic Strategies for Severe Community-Acquired Pneumonia.
Bassetti M, Giacobbe DR, Magnasco L, Fantin A, Vena A, Castaldo N. Bassetti M, et al. Among authors: magnasco l. Semin Respir Crit Care Med. 2024 Apr;45(2):187-199. doi: 10.1055/s-0043-1778641. Epub 2024 Feb 1. Semin Respir Crit Care Med. 2024. PMID: 38301712 Review.
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG.
Giacobbe DR, Dettori S, Di Pilato V, Asperges E, Ball L, Berti E, Blennow O, Bruzzone B, Calvet L, Capra Marzani F, Casabella A, Choudaly S, Dartevel A, De Pascale G, Di Meco G, Fallon M, Galerneau LM, Gallego M, Giacomini M, González Sáez A, Hänsel L, Icardi G, Koehler P, Lagrou K, Lahmer T, Lewis White P, Magnasco L, Marchese A, Marelli C, Marín-Arriaza M, Martin-Loeches I, Mekontso-Dessap A, Mikulska M, Mularoni A, Nordlander A, Poissy J, Russelli G, Signori A, Tascini C, Vaconsin LM, Vargas J, Vena A, Wauters J, Pelosi P, Timsit JF, Bassetti M; JIR-ICU investigators (collaborators); Critically Ill Patients Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESGCIP), and the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG). Giacobbe DR, et al. Among authors: magnasco l. Crit Care. 2023 Aug 24;27(1):323. doi: 10.1186/s13054-023-04608-1. Crit Care. 2023. PMID: 37620828 Free PMC article.
The Role of PCSK9 in Infectious Diseases.
Magnasco L, Sepulcri C, Antonello RM, Di Bella S, Labate L, Luzzati R, Giacobbe DR, Bassetti M. Magnasco L, et al. Curr Med Chem. 2022;29(6):1000-1015. doi: 10.2174/0929867328666210714160343. Curr Med Chem. 2022. PMID: 34269657 Free article.
In vivo evolution to echinocandin resistance and increasing clonal heterogeneity in Candida auris during a difficult-to-control hospital outbreak, Italy, 2019 to 2022.
Codda G, Willison E, Magnasco L, Morici P, Giacobbe DR, Mencacci A, Marini D, Mikulska M, Bassetti M, Marchese A, Di Pilato V. Codda G, et al. Among authors: magnasco l. Euro Surveill. 2023 Apr;28(14):2300161. doi: 10.2807/1560-7917.ES.2023.28.14.2300161. Euro Surveill. 2023. PMID: 37022211 Free PMC article.
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI.
Papavramidis T, Gentile I, Cattelan AM, Magnasco L, Viale P, Francisci D, Kofteridis DP, Tiseo G, Giamarellos-Bourboulis EJ, Lagi F, Pinna SM, D'Amico F, La Ferla L, Panagopoulos P, Gattuso G, Sipsas NV, Ruggieri A, Cattaneo A, Corio L, Comandini A, Mascagni P, Bassetti M. Papavramidis T, et al. Among authors: magnasco l. Int J Antimicrob Agents. 2023 Apr;61(4):106746. doi: 10.1016/j.ijantimicag.2023.106746. Epub 2023 Feb 8. Int J Antimicrob Agents. 2023. PMID: 36758778 Free article.
Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges?
Vena A, Castaldo N, Magnasco L, Bavastro M, Limongelli A, Giacobbe DR, Bassetti M. Vena A, et al. Among authors: magnasco l. Expert Opin Pharmacother. 2023 Feb;24(3):331-346. doi: 10.1080/14656566.2022.2161885. Epub 2023 Jan 3. Expert Opin Pharmacother. 2023. PMID: 36548447 Review.
53 results